If you are wondering whether Alnylam Pharmaceuticals at around $392 a share still offers value after a huge run, you are not alone. This is exactly the question we will unpack here. Despite a choppy ...

Chinese technology stocks in U.S. markets are rebounding as trade deal progress lifts sentiment and major advances in chips, ...

For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics ( CRSP 0.76%) and Viking Therapeutics ( VKTX ...

Dirty vs. clean bulking - which one is right for you? We take a detailed look at the pros and cons of both methods to help ...

Pisces comes last, Construction work may be delayed due to lack of raw materials. Purva Bhadrapada: You may secure a good business deal. However, your parents’ health may cause concern. You will be ...

Weight loss jabs could be used to treat Alzheimer’s disease after a study found the drug may slow cognitive decline. Liraglutide, sold under the brand name Saxenda, is prescribed to control blood ...

A weight-loss jab prescribed to thousands of overweight patients on the NHS could come with another unintended benefit - slashing the progression of Alzheimer's disease. Doctors often offer patients ...

A breakthrough weight loss jab already prescribed to thousands of NHS patients could slash the risk of developing Alzheimer's, promising research suggests. Liraglutide — sold under the brand name ...

Steve Witkoff, the U.S. special envoy to the Middle East, will travel to Moscow on Monday, a U.S. official tells Fox News. The trip comes as peace talks between Ukraine and Russia show signs of ...

Gain Therapeutics’s (NASDAQ:GANX) is one of the 12 hot penny stocks to invest in right now. At the Society for Neuroscience annual meeting in San Diego on November 20, Gain Therapeutics, Inc.